Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeStance Health GroupLFST -2.33%54 3-Year Revenue Growth Rate is 14.60% as of Mar. 2026, which is 16% below its 10-year median of 17.40. GuruFocus rates LFST with a GF Scoreâ„¢ of 54/100 and a GF Valueâ„¢ of $8.35 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 611 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 72.5% on this metric.
During the past 12 months, LifeStance Health Group's average Revenue per Share Growth Rate was 12.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of LifeStance Health Group was 62.00% per year. The lowest was 14.60% per year. And the median was 17.40% per year.
LifeStance Health Group (NAS:LFST) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
LifeStance Health Group 3-Year Revenue Growth Rate Related Terms
LFST vs CON, BKD, NHC: 3-Year Revenue Growth Rate Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group 3-Year Revenue Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's 3-Year Revenue Growth Rate falls into.
LifeStance Health Group 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 14.60% mean?
LifeStance Health Group (LFST) has a 3-Year Revenue Growth Rate of 14.60% as of Mar. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for LifeStance Health Group and its competitors. This is 16% below median its historical median of 17.40. Over the past decade, LifeStance Health Group's 3-Year Revenue Growth Rate has ranged from 14.60 to 62.00. According to the industry distribution chart, LifeStance Health Group ranks #168 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 27.5%.
Is LifeStance Health Group's 3-Year Revenue Growth Rate too high?
LifeStance Health Group's current 3-Year Revenue Growth Rate of 14.60% is 16% below median its 10-year median of 17.40. Over the past 10 years, this metric has ranged from a low of 14.60 to a high of 62.00. The Healthcare Providers & Services industry median 3-Year Revenue Growth Rate is 6.90. LifeStance Health Group's value of 14.60% is 111.6% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #168 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Scoreâ„¢ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's 3-Year Revenue Growth Rate compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #168 out of 611 companies for 3-Year Revenue Growth Rate. This puts LifeStance Health Group in the upper half of its industry. The industry median 3-Year Revenue Growth Rate is 6.90. LifeStance Health Group's value of 14.60% is 111.6% above this benchmark. Historically, LifeStance Health Group's own 3-Year Revenue Growth Rate has ranged from 14.60 to 62.00 over the past decade. While the company's 10-year median is 17.40 vs. the industry median of 6.90, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Revenue Growth Rate among Healthcare Providers & Services companies is 6.90, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current 3-Year Revenue Growth Rate of 14.60% is 111.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Revenue Growth Rate is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current 3-Year Revenue Growth Rate is 14.60%, which is 16% below median its own 10-year median of 17.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.35, compared to a current price of $10.48 — trading 25.4% above its estimated fair value. The current 3-Year Revenue Growth Rate is 14.60%, which is 16% below median its 10-year median of 17.40 and 111.6% above the Healthcare Providers & Services industry median of 6.90. LifeStance Health Group's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current 3-Year Revenue Growth Rate is 14.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.48 is trading 25.4% above its estimated GF Value™ of $8.35.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
3-Year Revenue Growth Rate: 14.60% (16% below median its 10-year median of 17.40)
GF Value™: $8.35 vs. price of $10.48 (25.4% above fair value)
Industry Position: 111.6% above the Healthcare Providers & Services median (#168 of 611)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
54GF Score
Get the complete analysis for LFST
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
